InvestorsHub Logo

GS1

Followers 115
Posts 4767
Boards Moderated 0
Alias Born 07/11/2010

GS1

Re: Skeetz99 post# 110586

Sunday, 12/28/2014 9:07:52 AM

Sunday, December 28, 2014 9:07:52 AM

Post# of 130503
ESS acquisition is the real deal which most have overlooked...Once this trial starts and investors will notice how big is this.

ACAD is trading $30 per share on one drug that is yet to be approved by FDA.